Home
>
National Drug Code (NDC)
>
DIFLUNISAL
DIFLUNISAL - 64980-181-01 - (DIFLUNISAL)
Drug Information of DIFLUNISAL
| Product NDC: | 64980-181 |
| Proprietary Name: | DIFLUNISAL |
| Non Proprietary Name: | DIFLUNISAL |
| Active Ingredient(s): | 500 mg/1 & nbsp; DIFLUNISAL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DIFLUNISAL
| Product NDC: | 64980-181 |
| Labeler Name: | Rising Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202845 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120501 |
Package Information of DIFLUNISAL
| Package NDC: | 64980-181-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (64980-181-01) |
NDC Information of DIFLUNISAL
| NDC Code | 64980-181-01 |
| Proprietary Name | DIFLUNISAL |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (64980-181-01) |
| Product NDC | 64980-181 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DIFLUNISAL |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120501 |
| Marketing Category Name | ANDA |
| Labeler Name | Rising Pharmaceuticals Inc. |
| Substance Name | DIFLUNISAL |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
